Thông tin tài liệu

Full metadata record
DC FieldValueLanguage
dc.contributor.authorKlegerman, Melvin E.-
dc.description.abstractIn the SARS-CoV-2 coronavirus pandemic of 2019 (COVID-19), it has become evident that the ACE-2 receptor-binding domain (RBD) of the viral spike protein (SP) is the arget of neutralizing antibodies that comprise a critical element of protective immunit to the virus. The most definitive confirmation of this contention is that the two mRNA COVID-19 vaccines in general use, which elicit antibodies specific for the RBD, exhibit approximately 95% protective efficacy against COVID-19. A potential challenge to vaccine efficacy is the emergence of SARS-CoV-2 variants possessing multiple mutations affecting amino acid residues in the
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Vietnam*
dc.subjectĐột biếnvi
dc.subjectProtein RBDvi
dc.subjectSự ức chếvi
dc.subjectN501Y SARS-CoV-2 Spikevi
dc.titleRelative Mutant N501Y SARS-CoV-2 Spike Protein RBD Inhibition of Anti-Spike Protein IgG and ACE-2 Binding to Spike Protein Speciesvi
dc.typeJournal articlevi
dc.description.noteCC BY-NC-ND 4.0vi
Appears in Collections:OER - Kỹ thuật hóa học; Công nghệ sinh học - Thực phẩm; Công nghệ môi trường

Files in This Item:
  • OER000002965.pdf
      Restricted Access
    • Size : 219,83 kB

    • Format : Adobe PDF

  • This item is licensed under a Creative Commons License Creative Commons